Hysterectomy

Hackensack Meridian Hackensack University Medical Center Among First Hospitals in the World To Acquire and Use the Da Vinci 5 Multiport Robotic Surgical System

Retrieved on: 
Tuesday, April 9, 2024
Hackensack University Medical Center, Vibration, Hysterectomy, Health, Surgeon, Hackensack Meridian Health, Professor, Education, Patient, Hospital, Trauma, Research, Artificial intelligence, Force, Insufflation, Workflow, Patient safety, Fatigue, Intuitive Surgical, Intuition, Engineering, Dentistry

HACKENSACK, N.J., April 9, 2024 /PRNewswire/ -- Hackensack Meridian Hackensack University Medical Center, a center of excellence and an international leader in robotic-assisted surgery, was selected to be one of only 14 centers in the world, and the only in New Jersey, New York and Connecticut, to acquire the Intuitive Surgical da Vinci 5 multiport surgical system. With more than 10,000 times the computing power and the first-of-its-kind force-sensing technology, the da Vinci 5 is the most advanced surgical technology available.

Key Points: 
  • The Hackensack University Medical Center team performed the first procedures ever using the new system to treat the four patients on Monday, April 1, 2024.
  • Da Vinci 5 builds on Intuitive's da Vinci Xi's highly functional design, which surgeons and care teams around the world have used in more than 7 million procedures to date.
  • Expanded computing power and advanced data capabilities: Da Vinci 5 has more than 10,000 times the computing power of da Vinci Xi.
  • Robotic surgery innovations and "firsts" include:
    Robotic surgery began at Hackensack University Medical Center in 2000 with two da Vinci™ robots.

Intuitive Announces FDA Clearance of Fifth-Generation Robotic System, da Vinci 5

Retrieved on: 
Thursday, March 14, 2024
Vibration, Hysterectomy, Head, Surgeon, Webcast, Research, Trauma, Hospital, Artificial intelligence, Force, Insufflation, Workflow, Patient safety, Food, FDA, Intuition, Engineering, Dentistry

“We are pleased to receive FDA clearance for our fifth-generation robotic system, da Vinci 5,” said Gary Guthart, CEO.

Key Points: 
  • “We are pleased to receive FDA clearance for our fifth-generation robotic system, da Vinci 5,” said Gary Guthart, CEO.
  • Expanded computing power and advanced data capabilities: Da Vinci 5 has more than 10,000 times the computing power of da Vinci Xi.
  • Da Vinci 5 will initially be available to a small number of customers in the U.S. who collaborated with Intuitive during the development period and those with mature robotic surgery programs.
  • “We intend to launch da Vinci 5 more broadly in the U.S. and globally after we learn from and work with an initial smaller number of customers directly.”
    Da Vinci 5 is the latest addition to the da Vinci family, which includes multiport systems da Vinci X and da Vinci Xi, and the single-port system da Vinci SP.

Moon Surgical Expands to Gynecological Surgery

Retrieved on: 
Wednesday, April 3, 2024
Hysterectomy, Salpingo-oophorectomy, Cystectomy, Patient, SAN, Surgeon, Gynaecology, Curriculum, Maestro

Over the past few weeks, the commercial Maestro System has been used routinely by eight surgeons across two facilities in France in 20 different clinical indications covering abdominal, bariatric, and most recently, gynecological surgery.

Key Points: 
  • Over the past few weeks, the commercial Maestro System has been used routinely by eight surgeons across two facilities in France in 20 different clinical indications covering abdominal, bariatric, and most recently, gynecological surgery.
  • Hysterectomy, cystectomy, adnexectomy and ovariectomy procedures were completed following the same onsite, one-hour long training curriculum, as for the previously completed surgical cases with Maestro.
  • "Maestro's adaptability was already demonstrated in the field of digestive surgery, where the system has been used for pretty much any indication successfully.
  • Expanding our experience to gynecology is an exciting step towards our goal of providing unprecedented surgical assistance to soft tissue surgical teams everywhere," stated Anne Osdoit, CEO of Moon Surgical.

More hysterectomies can be averted with earlier uterine artery embolization for postpartum hemorrhage

Retrieved on: 
Saturday, March 23, 2024
Health, Postpartum bleeding, Hysterectomy, Uterus, Internal bleeding, Uterine artery embolization, Incidence, Abdominal pain, Patient, Uncontrolled, Research, Bleeding, University, Society, Artery, Woman, Treatment, Blood, Birth control

FAIRFAX, Va., March 23, 2024 /PRNewswire/ -- Early intervention with a minimally invasive treatment called uterine artery embolization (UAE) can help women avoid hysterectomy due to severe bleeding after childbirth, according to a new study being presented at the Society of Interventional Radiology Annual Scientific Meeting in Salt Lake City.

Key Points: 
  • The study was a retrospective review of 66 patients (median age, 31) who underwent UAE for uncontrolled postpartum hemorrhage at a single, high-volume medical center between 2014 and 2022.
  • Postpartum hemorrhage is a rare but potentially deadly complication of childbirth.
  • The study found that it was more likely to occur in patients who experienced greater blood loss before embolization.
  • Abstract #189 : Short-Term and Long-Term Outcomes of Uterine Artery Embolization for Treatment of Uncontrolled Post-Partum Hemorrhage.

Breakthrough in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion: Release of Positive Results from Multicenter Phase III Global Clinical Study

Retrieved on: 
Tuesday, March 19, 2024
Medicine, Cervical cancer, Patient, Cancer, HPV16, School, Congress, Gynaecology, Risk, Peking Union Medical College, Woman, LEEP, Safety, Gynecologic Oncology (journal), Pathology, Recurrence, Squamous intraepithelial lesion, Acceleration, Research, Șaeș, SGO, Death, National Cancer Center, Vaccination, Molina Healthcare, Annual general meeting, Health, Obstetrics, Hysterectomy, HSIL, Public health, Infection, Incidence, LSIL, HPV, Bleeding, Physician, Birth control

This study is a prospective, randomized, double-blinded, placebo-controlled multicenter Phase III global clinical study designed to evaluate the efficacy and safety of APL-1702 for the treatment of cervical HSIL.

Key Points: 
  • This study is a prospective, randomized, double-blinded, placebo-controlled multicenter Phase III global clinical study designed to evaluate the efficacy and safety of APL-1702 for the treatment of cervical HSIL.
  • Primary endpoint of the study is the proportion of responders at 6 months after the initial treatment.
  • The study is led by Dr. Jinghe Lang, an academician at Peking Union Medical College Hospital, Chinese Academy of Medical Sciences.
  • Dr. Linda Wu, Chief Development Officer of Asieris Pharmaceuticals, said, "We are extremely proud of the results from the international multicenter Phase III clinical study of APL-1702.

Theromics Inc. Receives National Science Foundation Grant for Innovative Ablation Therapy Technology

Retrieved on: 
Tuesday, March 12, 2024
Principal, Uterine fibroid, Hysterectomy, Thermal, National Science Foundation, Patient, Research, Dartmouth College, Kansas State University, Brown University, NSF, Publication, Phase, FDA

WEST BRIDGEWATER, Mass., March 12, 2024 /PRNewswire/ -- Theromics Inc., a leading developer of products for the interventional oncology and interventional radiology markets, has announced the receipt of a $1M STTR Phase II grant from the National Science Foundation. The funding will support further studies of the company's innovative technology, HeatSYNC™, a nano-polymer gel designed to enhance the effectiveness of ablation therapy of abnormal tissue and allow controlled delivery of drugs directly into soft tissue with reduced side effects.

Key Points: 
  • WEST BRIDGEWATER, Mass., March 12, 2024 /PRNewswire/ -- Theromics Inc ., a leading developer of products for the interventional oncology and interventional radiology markets, has announced the receipt of a $1M STTR Phase II grant from the National Science Foundation.
  • The funding will support further studies of the company's innovative technology, HeatSYNC™, a nano-polymer gel designed to enhance the effectiveness of ablation therapy of abnormal tissue and allow controlled delivery of drugs directly into soft tissue with reduced side effects.
  • Damian Dupuy, MD, co-founder and chief medical officer of Theromics, will oversee ablation procedures at the various institutions.
  • Dr. Dupuy has over two hundred publications in professional journals and is one of the pioneers in image-guided thermal ablation.

Where’s Kate? Speculation about the ‘missing’ princess is proof the Palace’s media playbook needs a re-write

Retrieved on: 
Wednesday, March 13, 2024
Online, Sandringham, Associated Press, Social media, Reuters, AFP, Breeding, Catherine, Princess of Wales, Easter, Coma, News, Incest, English, Duke, Pleasure, TMZ, Nausea, Vomiting, Pregnancy, Hysterectomy, Getty Images, Health, Princess, Hyperemesis gravidarum, Kensington Palace, Death, Practice, Divorce, Child, Comment, Buckingham Palace, Cancer

Social media have been awash with speculation about Catherine’s health and whereabouts.

Key Points: 
  • Social media have been awash with speculation about Catherine’s health and whereabouts.
  • As scrutiny reaches a fever pitch, we ask: why is the Palace’s typical media playbook no longer working?

Not so ‘unprecedented’

  • Anne Boleyn (circa 1501-1536), the second of six wives of Henry VIII, was executed after being found guilty of adultery, incest and treason.
  • The long-reigning Queen Victoria (1819-1901) was widely regarded as as a loyal wife and mother.
  • Yet she too became the target of gossip regarding her close friendship with Scottish servant John Brown after her husband, Prince Albert, died in 1861.

The Palace’s strategic communications

  • The royal family has gradually adjusted to new media and technologies, though not as quickly as the public might like.
  • On one hand, the Palace continues its age-old tradition of announcing major news on a noticeboard at the gates of Buckingham Palace.

Internet sleuthing and a manipulated image

  • There were also more serious claims that she was in a coma, or dead, or getting a divorce.
  • In the midst of this speculation, TMZ published a grainy photo of Catherine in the passenger seat of a car near Windsor Castle.
  • The public quickly realised the image was at best poorly photoshopped or at worst AI-generated.
  • The Associated Press, Getty Images, AFP and Reuters subsequently issued “kill notices” on the image, stating concerns it had been digitally manipulated.

Old media PR won’t work in a new media world

  • The situation with Catherine’s absence from public life exposes the limits of old media strategies in a “new media” world.
  • The Palace is used to being able to control media coverage through the royal rota, a select group of press outlets in the UK given access to royal events.
  • Yet the interest in Catherine’s health has prompted a number of statements to the press.
  • These old media strategies don’t seem to be working, with news outlets that are part of the royal rota reporting critically on the manipulated image.


The authors do not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.

SS Innovations Launches Groundbreaking Inaugural Multi-Specialty Robotic Surgical Conference

Retrieved on: 
Monday, January 22, 2024
Aster, Artificial intelligence, General surgery, Urology, Apollo Hospitals, The Honourable, RGCI, Hysterectomy, Cholecystectomy, Medanta, OTC, Conference, Hospital, Cystectomy, Mantra, Incisional hernia, Medical device

FORT LAUDERDALE, Fla., Jan. 22, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, is proud to have presented the inaugural SS Innovations Multi-Specialty Robotic Surgical Conference (SMRSC), that was held at The Leela Ambience Hotel in Gurugram, Haryana, India on January 19 and 20, 2024. The meeting was highly attended with more than 600 visitors over the course of two days.

Key Points: 
  • 13 Live, broadcasted surgeries were performed by distinguished multi-specialty surgeons, using the SSi Mantra Surgical Robotic System
    Distinguished guests included the Honorable Governor of Haryana, Mr. Bandaru Dattatreya
    FORT LAUDERDALE, Fla., Jan. 22, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, is proud to have presented the inaugural SS Innovations Multi-Specialty Robotic Surgical Conference (SMRSC), that was held at The Leela Ambience Hotel in Gurugram, Haryana, India on January 19 and 20, 2024.
  • SMRSC 2024 was a transformative event that brought together global medical experts, technological innovators, and visionaries to explore the future of robotic surgery, with a specific focus on SS Innovations’ flagship surgical robotic system, the SSi Mantra.
  • SMRSC 2024 was a productive and educational event that showcased the SSi Mantra, SS Innovations’ technologically advanced, affordable, and accessible surgical robotic system, and SSi Maya, our groundbreaking virtual and mixed reality development division that we anticipate will allow us to launch robotic programs using tele-proctoring and tele-surgery.
  • The conference endeavors to set the stage for the future of healthcare with the SSi Mantra Surgical Robotic System.

Global Surgical Robots Market Forecast Report to 2030 - Partner & Customer Ecosystem Competitive Index & Regional Footprints - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 24, 2024
Biotechnology, Surgery, Health, Robotics, Technology, Artificial intelligence, CMR Surgical, Renishaw plc, Infection, Research, Bypass surgery, Hospital, Intuitive Surgical, Partner, Others, Surgeon, Stryker Corporation, AI, Government, Appendectomy, Algorithm, Risk, Johnson & Johnson, USD, Pain, Medtronic, Hysterectomy, Instrument, Machine learning, Colectomy, Region, Prostatectomy, Siemens Healthineers, Growth, Medical device

The "Global Surgical Robots Market 2030 by Product Type, Application, End-user, and Region - Partner & Customer Ecosystem Competitive Index & Regional Footprints" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Surgical Robots Market 2030 by Product Type, Application, End-user, and Region - Partner & Customer Ecosystem Competitive Index & Regional Footprints" report has been added to ResearchAndMarkets.com's offering.
  • Major players Surgical Robots Market include: Stryker Corporation, Medrobotics, Smith & Nephew, TransEnterix Surgical, Inc., Renishaw plc., Intuitive Surgical, Medtronic, THINK Surgical, Inc., Zimmer Biomet, Asensus Surgical, Siemens Healthineers, CMR Surgical, Johnson & Johnson, Renishaw Plc.
  • The demand for these computer-assisted surgical systems is substantial, being utilized in open surgeries, laparoscopic procedures, and flexible endoscopic procedures.
  • One key trend in the Surgical Robots Market is the integration of artificial intelligence (AI) and machine learning (ML) technologies into surgical robotic systems.

Global Surgical Robots Market Report 2024 - Projected at USD 7.3 Billion by 2030: Integration of AI & High Demand for Minimally Invasive Surgeries Propel North America to the Forefront

Retrieved on: 
Wednesday, January 24, 2024
Artificial intelligence, CMR Surgical, Renishaw plc, Infection, Research, Bypass surgery, Hospital, Intuitive Surgical, Partner, Others, Surgeon, Stryker Corporation, AI, Government, Appendectomy, Algorithm, Risk, Johnson & Johnson, USD, Pain, Medtronic, Hysterectomy, Instrument, Machine learning, Colectomy, Region, Prostatectomy, Siemens Healthineers, Growth, Medical device

Major players Surgical Robots Market include: Stryker Corporation, Medrobotics, Smith & Nephew, TransEnterix Surgical, Inc., Renishaw plc., Intuitive Surgical, Medtronic, THINK Surgical, Inc., Zimmer Biomet, Asensus Surgical, Siemens Healthineers, CMR Surgical, Johnson & Johnson, Renishaw Plc.

Key Points: 
  • Major players Surgical Robots Market include: Stryker Corporation, Medrobotics, Smith & Nephew, TransEnterix Surgical, Inc., Renishaw plc., Intuitive Surgical, Medtronic, THINK Surgical, Inc., Zimmer Biomet, Asensus Surgical, Siemens Healthineers, CMR Surgical, Johnson & Johnson, Renishaw Plc.
  • The use of medical robotic systems has become widespread in the fields of gynaecology and cosmetology, particularly for minimally invasive surgeries.
  • The demand for these computer-assisted surgical systems is substantial, being utilized in open surgeries, laparoscopic procedures, and flexible endoscopic procedures.
  • One key trend in the Surgical Robots Market is the integration of artificial intelligence (AI) and machine learning (ML) technologies into surgical robotic systems.